Dietary formula may shield menopausal Women's brains from Obesity-Linked decline

NCT ID NCT07501377

Recruiting now Prevention Sponsor: Max Planck Institute for Human Cognitive and Brain Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a daily powder containing fiber and plant compounds (inulin, resveratrol, quercetin) can reduce brain inflammation in 120 overweight women aged 35-60 who are going through menopause. Participants take the supplement or a placebo for 6 months, and researchers use brain scans and blood/stool tests to measure changes. The goal is to see if improving gut health can protect the brain from inflammation and lower the risk of memory problems later in life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIMENOPAUSAL WOMEN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction Neuroinflammatory Diseases Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVERWEIGHT AND/OR OBESITY PERIMENOPAUSAL WOMEN

Contacts and locations

Show contact details

Locations

Max Planck Institute for Human Cognitive and Brain Sciences
RECRUITING

Leipzig, Saxony, 04103, Germany

Contact Phone: •••-•••-•••• Email: •••••@•••••